Showing results (421-430 of 446) with videos related to

Sort By:
Pageof 45
Cell Reports. Medicine|May 19, 2022
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodiesKattria van der Ploeg, Adam S Kirosingh, Diego A M Mori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetesPeer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Molecular Genetics and Metabolism|July 3, 2026
Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX)Karl E Anderson, Robert J Desnick, Herbert L Bonkovsky, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraineBrendan M Crowley, Craig A Stump, Diem N Nguyen, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
Elife|October 14, 2022
Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics studyZicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonistsZhili Xin, Michael D Serby, Hongyu Zhao, et al.
Annals of Internal Medicine|March 20, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 HospitalizationTracy Y Wang, Abdus S Wahed, Alison Morris, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery and metabolic stabilization of potent and selective 2-amino-N-(adamant-2-yl) acetamide 11beta-hydroxysteroid dehydrogenase type 1 inhibitorsJeffrey J Rohde, Marina A Pliushchev, Bryan K Sorensen, et al.
JAMA Internal Medicine|June 7, 2024
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical TrialLinda N Geng, Hector Bonilla, Haley Hedlin, et al.
Pageof 45